VCM
DXCM icon

Vigilant Capital Management’s DexCom DXCM Stock Holding History

Vigilant Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-68
Closed -$5K – 584
2022
Q2 		$5K Buy
+68
New +$6.21K ﹤0.01% 518
2016
Q3 		– Sell
-644
Closed -$13K – 315
2016
Q2 		$13K Buy
+644
New +$11K ﹤0.01% 259

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vigilant Capital Management's DXCM Position: Q3 2022 in Review

Vigilant Capital Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 68 shares — an estimated $5K sold.

Vigilant Capital Management first reported a position in DXCM in Q2 2016 and held it in 2 quarters. The position peaked at $13K in Q2 2016. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Vigilant Capital Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Vigilant Capital Management sold 68 DexCom shares in Q3 2022, an estimated $5K.
  • Vigilant Capital Management first reported a position in DexCom in Q2 2016 and held it in 2 quarters.
  • Vigilant Capital Management's DexCom position peaked at $13K in Q2 2016.
  • 795 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Vigilant Capital Management's 13F filing for Q3 2022, filed 25 Oct 2022.